Results 11 to 20 of about 9,376,530 (330)

Hematological Diseases and Osteoporosis [PDF]

International Journal of Molecular Sciences, 2020
Secondary osteoporosis is a common clinical problem faced by bone specialists, with a higher frequency in men than in women. One of several causes of secondary osteoporosis is hematological disease. There are numerous hematological diseases that can have a deleterious impact on bone health.
Gaudio A., Xourafa A., Rapisarda R., Zanoli L., Signorelli S. S., Castellino P.   +5 more
openaire   +3 more sources

Salient features of hematological diseases [PDF]

Annals of Oncology, 2007
M.F. Fey
openalex   +6 more sources

Advancing therapeutic complement inhibition in hematologic diseases: PNH and beyond.

Blood, 2021
Complement is an elaborate system of the innate immunity. Genetic variants and autoantibodies leading to excessive complement activation are implicated in a variety of human diseases.
E. Gavriilaki, R. Peffault de Latour, A. Risitano   +2 more
semanticscholar   +1 more source

Management and Clinical Outcome of Posterior Reversible Encephalopathy Syndrome in Pediatric Oncologic/Hematologic Diseases: A PRES Subgroup Analysis With a Large Sample Size

Frontiers in Pediatrics, 2021
This study investigated the management and clinical outcomes along with associated factors of posterior reversible encephalopathy syndrome (PRES) in childhood hematologic/oncologic diseases.
Marady Hun, Min Xie, Z. She, A. S. Abdirahman, Cuifang Li, Feifeng Wu, Senlin Luo, Phanna Han, Rithea Phorn, P. Wu, Haiyan Luo, Keke Chen, Jidong Tian, W. Wan, Chuan Wen   +14 more
semanticscholar   +1 more source

CD7-directed CAR T-cell therapy: a potential immunotherapy strategy for relapsed/refractory acute myeloid leukemia

Experimental Hematology & Oncology, 2022
Relapsed/refractory acute myeloid leukemia (AML) patients generally have a dismal prognosis and the treatment remains challenging. Due to the expression of CD7 on 30% AML and not on normal myeloid and erythroid cells, CD7 is an attractive target for ...
Xuanqi Cao, Haiping Dai, Qingya Cui, Zheng Li, Wenhong Shen, Jinlan Pan, Hongjie Shen, Qinfen Ma, Mengyun Li, Sifan Chen, Juncheng Chen, Xiaming Zhu, Huimin Meng, Lin Yang, Depei Wu, Xiaowen Tang   +15 more
doaj   +1 more source

Which one is better for refractory/relapsed acute B-cell lymphoblastic leukemia: Single-target (CD19) or dual-target (tandem or sequential CD19/CD22) CAR T-cell therapy?

Blood Cancer Journal, 2023
CD19 chimeric antigen receptor (CAR) T-cell therapy has shown great success against B-cell acute lymphoblastic leukemia (B-ALL). Tandem and sequential CD19/CD22 dual-target CAR T-cell therapies have been developed to reduce the possibility of CD19 ...
Sining Liu, Xinyue Zhang, Haiping Dai, Wei Cui, Jia Yin, Zheng Li, Xiao Yang, Chunxiu Yang, Shengli Xue, Huiying Qiu, Miao Miao, Suning Chen, Zhengming Jin, Chengcheng Fu, Caixia Li, Aining Sun, Yue Han, Ying Wang, Lei Yu, Depei Wu, Qingya Cui, Xiaowen Tang   +21 more
doaj   +1 more source

Clinical characteristics and prognostic significance of DNA methylation regulatory gene mutations in acute myeloid leukemia

Clinical Epigenetics, 2023
Background DNA methylation is a form of epigenetic modification that regulates gene expression. However, there are limited data on the comprehensive analysis of DNA methylation regulated gene mutations (DMRGM) in acute myeloid leukemia (AML) mainly ...
Xiaoyan Xu, Hong Wang, Haohao Han, Yifang Yao, Xueqian Li, Jiaqian Qi, Chengsen Cai, Meng Zhou, Yaqiong Tang, Tingting Pan, Ziyan Zhang, Jingyi Yang, Depei Wu, Yue Han   +13 more
doaj   +1 more source

Movement Disorders and Hematologic Diseases. [PDF]

Mov Disord Clin Pract, 2021
AbstractBackgroundMovement disorders can be associated with or caused by hematological abnormalities. The objective of this review is to highlight features that will aid in the clinician's recognition and treatment of these disorders.MethodsMESH terms relevant to movement disorders and hematologic diseases were searched to identify conditions included ...
Patel RA, Hall DA, Eichenseer S, Bailey M.   +3 more
europepmc   +5 more sources

Hope for hematological diseases [PDF]

Science, 2020
Tweaking growth media helps cultured hematopoietic stem cells ...
openaire   +3 more sources

Microbiota and Hematological Diseases

International Journal of Hematology-Oncology and Stem Cell Research, 2022
The microbiota is directly involved in the host metabolic process, as well as in immune response modulation and recruitment of different cells typology in the inflammatory site. Human microbiota modification (dysbiosis) is a condition which could be correlated with various pathologies.
openaire   +3 more sources